These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30895275)

  • 1. The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia.
    Martin A; Stillman J; Miguez MJ; McDaniel HR; Konefal J; Woolger JM; Lewis JE
    J Clin Transl Res; 2018 Jan; 3(3):337-343. PubMed ID: 30895275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between brain-derived neurotrophic factor and immune function during dietary supplement treatment of elderly with Alzheimer's dementia.
    Stillman J; Martin A; Miguez MJ; McDaniel HR; Konefal J; Woolger JM; Lewis JE
    J Clin Transl Res; 2020 Jan; 5(2):68-75. PubMed ID: 32377581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in Alzheimer's disease.
    Lewis JE; McDaniel HR; Agronin ME; Loewenstein DA; Riveros J; Mestre R; Martinez M; Colina N; Abreu D; Konefal J; Woolger JM; Ali KH
    J Alzheimers Dis; 2013; 33(2):393-406. PubMed ID: 22976077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Plasma Pro-Brain-Derived Neurotrophic Factor (proBDNF)/Mature Brain-Derived Neurotrophic Factor (mBDNF) Levels with BDNF Gene Val66Met Polymorphism in Alcohol Dependence.
    Mo M; Fu XY; Zhang XL; Zhang SC; Zhang HQ; Wu L; Li JL; Zhou L
    Med Sci Monit; 2021 Aug; 27():e930421. PubMed ID: 34415897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum brain-derived neurotrophic factor as diagnosis clue for Alzheimer's disease: A cross-sectional observational study in the elderly.
    Li Y; Chen J; Yu H; Ye J; Wang C; Kong L
    Front Psychiatry; 2023; 14():1127658. PubMed ID: 37009109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
    Yoshida T; Ishikawa M; Niitsu T; Nakazato M; Watanabe H; Shiraishi T; Shiina A; Hashimoto T; Kanahara N; Hasegawa T; Enohara M; Kimura A; Iyo M; Hashimoto K
    PLoS One; 2012; 7(8):e42676. PubMed ID: 22880079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.
    Michalski B; Fahnestock M
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):148-54. PubMed ID: 12654514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum proBDNF Is Associated With Changes in the Ketone Body β-Hydroxybutyrate and Shows Superior Repeatability Over Mature BDNF: Secondary Outcomes From a Cross-Over Trial in Healthy Older Adults.
    Norgren J; Daniilidou M; Kåreholt I; Sindi S; Akenine U; Nordin K; Rosenborg S; Ngandu T; Kivipelto M; Sandebring-Matton A
    Front Aging Neurosci; 2021; 13():716594. PubMed ID: 34489682
    [No Abstract]   [Full Text] [Related]  

  • 11. No association of both serum pro-brain-derived neurotrophic factor (proBDNF) and BDNF concentrations with depressive state in community-dwelling elderly people.
    Ohto A; Mizoguchi Y; Imamura Y; Kojima N; Yamada S; Monji A
    Psychogeriatrics; 2021 Jul; 21(4):503-513. PubMed ID: 33878808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of hippocampal GABAergic transmission impairs memory in rodent models of Alzheimer's disease.
    Bie B; Wu J; Lin F; Naguib M; Xu J
    Eur J Pharmacol; 2022 Feb; 917():174771. PubMed ID: 35041847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts.
    Södersten K; Pålsson E; Ishima T; Funa K; Landén M; Hashimoto K; Ågren H
    J Affect Disord; 2014 May; 160():1-9. PubMed ID: 24709015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing.
    Fleitas C; Piñol-Ripoll G; Marfull P; Rocandio D; Ferrer I; Rampon C; Egea J; Espinet C
    Mol Brain; 2018 Nov; 11(1):68. PubMed ID: 30428894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice.
    Xue Z; Shui M; Lin X; Sun Y; Liu J; Wei C; Wu A; Li T
    Front Aging Neurosci; 2022; 14():780972. PubMed ID: 35370607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets Selectively Regulate the Release of BDNF, But Not That of Its Precursor Protein, proBDNF.
    Le Blanc J; Fleury S; Boukhatem I; Bélanger JC; Welman M; Lordkipanidzé M
    Front Immunol; 2020; 11():575607. PubMed ID: 33324399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of blood proBDNF and its receptors in major depression.
    Zhou L; Xiong J; Lim Y; Ruan Y; Huang C; Zhu Y; Zhong JH; Xiao Z; Zhou XF
    J Affect Disord; 2013 Sep; 150(3):776-84. PubMed ID: 23537780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.